139 related articles for article (PubMed ID: 28474845)
21. Stereotyped B-cell receptors in the context of a diverse Brazilian series of chronic lymphocytic leukemia.
Torres DC; Emmel V; Tascheri V; Campos MM; Bigni RS; Sabino AP; Yamamoto M; Campregher PV; Muniz MTC; Abdelhay E; Hassan R
Blood Cells Mol Dis; 2021 Feb; 86():102491. PubMed ID: 32911384
[No Abstract] [Full Text] [Related]
22. When and how to treat chronic lymphocytic leukemia.
Dighiero G; Binet JL
N Engl J Med; 2000 Dec; 343(24):1799-801. PubMed ID: 11114321
[No Abstract] [Full Text] [Related]
23. Chronic lymphocytic leukemia.
Shanshal M; Haddad RY
Dis Mon; 2012 Apr; 58(4):153-67. PubMed ID: 22449365
[No Abstract] [Full Text] [Related]
24. Incidence of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis in Calgary, Alberta, Canada.
Healey R; Patel JL; de Koning L; Naugler C
Leuk Res; 2015 Apr; 39(4):429-34. PubMed ID: 25703352
[TBL] [Abstract][Full Text] [Related]
25. Chronic lymphocytic leukemia: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Eichhorst B; Hallek M; Dreyling M;
Ann Oncol; 2008 May; 19 Suppl 2():ii60-2. PubMed ID: 18456771
[No Abstract] [Full Text] [Related]
26. Diagnosing and treating chronic lymphocytic leukemia in 2009.
Kaufman M; Rubin J; Rai K
Oncology (Williston Park); 2009 Nov; 23(12):1030-7. PubMed ID: 20017285
[TBL] [Abstract][Full Text] [Related]
27. A scoring system to predict the risk of atrial fibrillation in chronic lymphocytic leukemia.
Visentin A; Deodato M; Mauro FR; Autore F; Reda G; Vitale C; Molica S; Rigolin GM; Piazza F; Cesini L; Tedeschi A; Laurenti L; Cassin R; Coscia M; Cuneo A; Foà R; Semenzato G; Trentin L
Hematol Oncol; 2019 Oct; 37(4):508-512. PubMed ID: 31335982
[No Abstract] [Full Text] [Related]
28. Overexpressed BAG3 is a potential therapeutic target in chronic lymphocytic leukemia.
Zhu H; Wu W; Fu Y; Shen W; Miao K; Hong M; Xu W; Young KH; Liu P; Li J
Ann Hematol; 2014 Mar; 93(3):425-35. PubMed ID: 23978946
[TBL] [Abstract][Full Text] [Related]
29. Upper aerodigestive tract cancer in patients with chronic lymphocytic leukemia: incidence, stage, and outcome.
Pagedar NA; Halfdanarson TR; Karnell LH; Hoffman HT; Funk GF
Arch Otolaryngol Head Neck Surg; 2012 Dec; 138(12):1171-5. PubMed ID: 23247237
[TBL] [Abstract][Full Text] [Related]
30. [Chronic lymphatic leukemia].
Hinterberger W
Wien Med Wochenschr; 1991; 141(9-10):198-201. PubMed ID: 1949842
[TBL] [Abstract][Full Text] [Related]
31. Long-term survival among patients with chronic lymphocytic leukemia (CLL) treated in Department of Hematology, Medical University of Lublin.
Sokołowska B; Wasik E; Kniaź M; Brzozowska J; Podhorecka M; Sledzińska M; Domański D
Ann Univ Mariae Curie Sklodowska Med; 2000; 55():103-9. PubMed ID: 11482058
[No Abstract] [Full Text] [Related]
32. Chronic lymphocytic leukemia: the most common leukemia in adults.
Washburn L
JAAPA; 2011 May; 24(5):54-8 Quiz 59. PubMed ID: 21574533
[No Abstract] [Full Text] [Related]
33. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.
Rai KR; Peterson BL; Appelbaum FR; Kolitz J; Elias L; Shepherd L; Hines J; Threatte GA; Larson RA; Cheson BD; Schiffer CA
N Engl J Med; 2000 Dec; 343(24):1750-7. PubMed ID: 11114313
[TBL] [Abstract][Full Text] [Related]
34. Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience.
Laurenti L; Chiusolo P; Tarnani M; Balducci M; Piccirillo N; Sora F; Sica S; Leone G
Hematol Oncol; 2011 Jun; 29(2):107-10. PubMed ID: 20568076
[No Abstract] [Full Text] [Related]
35. Malignant lymphoma of the lacrimal gland: a nation-based study.
Rasmussen P; Ralfkiaer E; Prause JU; Sjö LD; Siersma VD; Heegaard S
Arch Ophthalmol; 2011 Oct; 129(10):1275-80. PubMed ID: 21987669
[TBL] [Abstract][Full Text] [Related]
36. [Multiple myeloma and chronic lymphocytic leukemia].
Labardini-Méndez J; Alexanian R; Barlogie B
Rev Invest Clin; 1997 May; 49 Suppl 1():28-33. PubMed ID: 9380986
[No Abstract] [Full Text] [Related]
37. [Chronic lymphatic leukemia. Progress in diagnosis and therapy].
Borchmann P; Diehl V; Engert A
Internist (Berl); 1996 Oct; 37(10):1022-9. PubMed ID: 9019446
[No Abstract] [Full Text] [Related]
38. Clinical staging and prognostic markers in chronic lymphocytic leukemia.
Rai KR; Wasil T; Iqbal U; Driscoll N; Patel D; Janson D; Mehrotra B
Hematol Oncol Clin North Am; 2004 Aug; 18(4):795-805, vii. PubMed ID: 15325699
[TBL] [Abstract][Full Text] [Related]
39. A review of pharmacologic options for previously untreated chronic lymphocytic leukemia.
Wilhelm K; Yang D
J Oncol Pharm Pract; 2011 Jun; 17(2):91-103. PubMed ID: 20085962
[TBL] [Abstract][Full Text] [Related]
40. Recent advances in the treatment of chronic lymphocytic leukemia: defining the role of intravenous immunoglobulin.
Besa EC
Semin Hematol; 1992 Jul; 29(3 Suppl 2):14-23. PubMed ID: 1380736
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
